Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 4
Submit an article Journal homepage
54
Views
11
CrossRef citations to date
0
Altmetric
Special Report

The German method for setting ceiling prices for drugs: in some cases less data are required

Afschin Gandjour Department of Public Health, Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany. [email protected]; Department of Public Health, Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany. [email protected]
&
Amiram Gafni Centre for Health Economics and Policy Analysis and the Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Centre for Health Economics and Policy Analysis and the Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
Pages 403-409 | Published online: 09 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Frank G. Sandmann, Sarah Mostardt, Stefan K. Lhachimi & Andreas Gerber-Grote. (2018) The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?. Expert Review of Pharmacoeconomics & Outcomes Research 18:5, pages 475-486.
Read now
Afschin Gandjour, Amiram Gafni & Michael Schlander. (2014) Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor. Expert Review of Pharmacoeconomics & Outcomes Research 14:1, pages 123-129.
Read now
Afschin Gandjour. (2012) Cost–effectiveness of preventing weight gain and obesity: what we know and what we need to know. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 297-305.
Read now

Articles from other publishers (8)

Afschin Gandjour. (2023) Value-based pricing of add-on life-extending medicines based on economic evaluation. British Journal of Healthcare Management 29:8, pages 1-7.
Crossref
Afschin Gandjour. (2020) A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency. BMC Health Services Research 20:1.
Crossref
Afschin Gandjour. (2015) Comment on: “Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy”. PharmacoEconomics 33:9, pages 981-982.
Crossref
Afschin Gandjour. (2014) Comment on: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”. PharmacoEconomics 32:12, pages 1245-1246.
Crossref
Afschin Gandjour, Nadja Chernyak, Andrea Icks & Amiram Gafni. (2014) Public acceptance of different approaches to determine drug reimbursement prices and whether it is influenced by framing. International Journal of Public Sector Management 27:6, pages 501-511.
Crossref
Andreas Gerber-Grote, Frank Gerd Sandmann, Min Zhou, Corinna ten Thoren, Anja Schwalm, Carolin Weigel, Christiane Balg, Alexander Mensch, Sarah Mostardt, Astrid Seidl & Stefan K. Lhachimi. (2014) Decision making in Germany: Is health economic evaluation as a supporting tool a sleeping beauty?. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 108:7, pages 390-396.
Crossref
Afschin Gandjour. (2012) Reference Pricing and Price Negotiations for Innovative New Drugs. PharmacoEconomics 31:1, pages 11-14.
Crossref
Afschin Gandjour. (2011) Presenting Germany’s drug pricing rule as a cost-per-QALY rule. Health Care Management Science 15:2, pages 103-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.